Stocktoria
Sotera Health Co SHC
Sotera Health Co financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.0B | $1.0B | $931.5M | $818.2M |
| Gross profit | $645.5M | $602.3M | $577.2M | $557.0M | $518.7M | $443.6M |
| SG&A expense | $252.8M | $242.6M | $236.7M | $245.7M | $198.2M | $178.5M |
| Operating income | — | $297.6M | $276.7M | $248.3M | $256.7M | $206.0M |
| Income tax | $69.6M | $69.5M | $54.7M | -$9.5M | $58.6M | -$1.4M |
| Net income | $77.9M | $44.4M | $51.4M | -$233.6M | $116.9M | -$38.6M |
| EPS (diluted) | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 | $-0.16 |
| Operating cash flow | $287.2M | $224.2M | -$147.7M | $278.0M | $281.5M | $120.6M |
| Free cash flow | $149.2M | $45.1M | -$362.7M | $95.6M | $179.4M | $67.1M |
| Cash & equivalents | $344.6M | $277.2M | $296.4M | $395.2M | $106.9M | $102.4M |
| Inventory | $54.4M | $49.2M | $48.3M | $37.1M | $54.3M | $34.1M |
| Total assets | $3.3B | $3.1B | $3.1B | $3.1B | $2.8B | $2.8B |
| Total liabilities | $2.7B | $2.7B | $2.7B | $2.8B | $2.2B | $2.3B |
| Shareholders' equity | $606.0M | $404.9M | $443.7M | $350.2M | $586.1M | $454.6M |
Growth · year-over-year · Revenue CAGR 7.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +5.7% | +4.9% | +4.5% | +7.8% | +13.9% | — |
| Net income growth | +75.6% | -13.6% | — | -299.8% | — | — |
| EPS growth | +68.8% | -11.1% | — | -302.4% | — | — |
| Free cash flow growth | +230.8% | — | -479.5% | -46.7% | +167.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.